comprehensive -WSS

comprehensive

author：fashion 2025-10-01 23:57:36 - browse：39167

The term “excited delirium” has been used for years by law enforcement and other first responders, including health care workers, to describe people who exhibit behavior that is considered “out of control.” This diagnosis has been applied again and again, even posthumously, as a justification for extreme, and sometimes deadly, interventions by law enforcement. It came up most recently in the trials of two police officers accused of causing the death of Elijah McClain, a Colorado man; both officers were acquitted this week.

But excited delirium is not an evidence-based medical diagnosis. The American College of Emergency Physicians recently withdrew a 2009 white paper endorsing the concept, and California has banned it as a cause of death. Other states may follow suit.

On this week’s episode, we are joined by Utsha G. Khatri, an assistant professor of emergency medicine and population health and policy at the Icahn School of Medicine at Mount Sinai, and emergency physician Brooks Walsh, who was involved with the campaign to get ACEP to withdraw the 2009 white paper. Khatri and Walsh speak about why the “excited delirium” label is both unnecessary and dangerous.

“We recognize that some patients are confused. They’re not thinking clearly they might have risk for becoming violent either toward themselves or towards other staff,” Khatri said. “It is our job not just to keep them and everyone else safe, but also to most importantly find out what is causing them to act in this way.”

You can read Khatri’s First Opinion essay on the end of “excited delirium” here.

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts.

Previous article： Medical records are filled with copy
Next article： Biotech stock slump in 2023: awaiting the turnaround

WSS

Experts study whether long Covid risk adds up with each reinfection

Experts study whether long Covid risk adds up with each reinfection

Mass General, Mayo Clinic look to monetize custom

FDA panel to weigh approval of NurOwn, controversial ALS drug

Mass General, Mayo Clinic look to monetize custom

TikTok, Instagram influencers need more rules for drug ads

explore

comprehensive

entertainment

State Dept. review finds Biden bears some blame for Afghanistan failures

Medicare bonuses could stop drug shortages under Senate plan

Moonlake's readout produced a cash windfall. Risks remain

FDA endorses new sterilization method for medical devices

Supreme Court strikes down use of affirmative action

TikTok, Instagram influencers need more rules for drug ads

The cancer drug shortage isn’t new — and neither are the solutions

Changes to biosimilar regulatory framework must prioritize patients

How one medical school became remarkably diverse

Senate HELP committee spars over health care workforce policies

focus

High breast density mammograms need follow

Why are Kaiser Permanente staff considering a strike?

A pediatrician calls for Congress to pass the child tax credit deal

To bolster infectious disease surveillance, genomics powerhouses team up

Experts study whether long Covid risk adds up with each reinfection

Second xenotransplant done with gene

leisure time

entertainment

Wikipedia

explore